News | April 12, 2011

Award to Promote Research Into MRI on Newborns at High Risk of Brain Injury

April 13, 2011 – The Wellcome Trust has awarded a Strategic Translation Award to GE Healthcare for research into the potential use of magnetic resonance imaging (MRI) for newborns at high risk of brain injury. This marks the first time GE Healthcare will collaborate with Wellcome Trust to extend the reach of MRI technology.

In the United Kingdom, approximately five in every thousand babies born suffer brain injury and of those, approximately one in five die. Babies that survive early brain injury are at high risk of developing long-term neurological problems. Improving the speed and accuracy of diagnosis into brain problems in babies is essential for improving clinical outcomes.

Ultrasound technology is most commonly used to image newborns that are at high risk of developing brain injury, largely because the technique can be performed within the neonatal unit at the hospital. MRI is widely accepted as being a better diagnostic tool; however in many centers it is not practical to take babies to an MRI scanner, which is usually located in another part of the hospital. As a result, the risk of removing a baby from the protective environment of the neonatal intensive care unit usually outweighs the potential benefit to be gained from MRI as a more sensitive imaging technique.

The award will initially be used to investigate how MRI could be placed within the neonatal unit itself, removing the need to transfer the infant. This research will lead to a better understanding of the technology required to care for infants in a neonatal intensive care environment.

“I am delighted that this partnership will facilitate the development of MRI imaging tailored to the needs of doctors caring for vulnerable young lives,” said Ted Bianco, director of technology transfer at the Wellcome Trust.

For more information: www.gehealthcare.com

Related Content

Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more
SBRT Considered Safe Treatment Option for Patients With Multiple Metastases
News | Stereotactic Body Radiation Therapy (SBRT) | November 01, 2018
The NRG Oncology clinical trial BR001 tested the hypothesis that stereotactic body radiotherapy (SBRT) could be used...
Hypofractionated Radiation Provides Same Prostate Cancer Outcomes as Conventional Radiation
News | Intensity Modulated Radiation Therapy (IMRT) | October 31, 2018
An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized prostate cancer with...
Prostate Brachytherapy Shows Low Incidence of Short-Term Complications
News | Brachytherapy Systems | October 31, 2018
A new analysis of nearly 600 men receiving brachytherapy for prostate cancer shows overall procedure-related...